Viewing Study NCT05185869


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2025-12-25 @ 8:44 PM
Study NCT ID: NCT05185869
Status: UNKNOWN
Last Update Posted: 2022-01-11
First Post: 2021-12-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module